New heart valve implant under observation: hope for aortic stenosis patients

NCT ID NCT05956652

First seen May 01, 2026 · Last updated May 01, 2026

Summary

This study is tracking 500 people with severe aortic stenosis who receive a new type of heart valve implant (Hydra TAVI system). The goal is to see how safe and effective the valve is over time, including risks like stroke or bleeding. Participants are chosen by their heart team and must agree to follow-up visits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fondazione Poliambulanza Istituto

    RECRUITING

    Brescia, 25124, Italy

  • IRCCS Ospedale Galeazzi-Sant'Ambrogio

    NOT_YET_RECRUITING

    Milan, 20157, Italy

  • Montevergine Clinic, Mercogliano, Italy

    RECRUITING

    Mercogliano, 83013, Italy

    Contact

  • Università degli studi di Padova

    NOT_YET_RECRUITING

    Padova, 35122, Italy

Conditions

Explore the condition pages connected to this study.